Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells (Q39771887)

14 September 2017

Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells (English)

1 reference

14 September 2017

Rocío García-Becerra

1

1 reference

14 September 2017

Lorenza Díaz

2

1 reference

14 September 2017

Javier Camacho

3

1 reference

14 September 2017

David Barrera

4

1 reference

14 September 2017

David Ordaz-Rosado

5

1 reference

14 September 2017

Angélica Morales

6

1 reference

14 September 2017

Cindy Sharon Ortiz

7

1 reference

14 September 2017

Euclides Avila

8

1 reference

14 September 2017

Enrique Bargallo

9

1 reference

14 September 2017

Myrna Arrecillas

10

1 reference

14 September 2017

Ali Halhali

11

1 reference

14 September 2017

Fernando Larrea

12

1 reference

14 September 2017

language of work or name

English

0 references

publication date

20 November 2009

1 reference

Experimental Cell Research

14 September 2017

1 reference

14 September 2017

316

1 reference

14 September 2017

3

1 reference

14 September 2017

433-442

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

14 September 2017

1 reference

Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D and prevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D and breast cancer: insights from animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Molecular actions of vitamin D contributing to cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Ether à go-go potassium channels and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

7 January 2021

Eag1 as a cancer target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Oncogenic potential of EAG K(+) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Overexpression of Eag1 potassium channels in clinical tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Breast cancer cell lines: friend or foe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Whole-cell uptake and nuclear localization of 1,25-dihydroxycholecalciferol by breast cancer cells (T47 D) in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Alternative splicing of the eag potassium channel gene in Drosophila generates a novel signal transduction scaffolding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Physiology of EAG K+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Remembrance of things PAS: regulation of development by bHLH-PAS proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D-3 receptor as a target for breast cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

Vitamin D inadequacy among post-menopausal women: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

High Prevalence of Vitamin D Inadequacy and Implications for Health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.11.008

10.1016/J.YEXCR.2009.11.008

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference